Cosmo Pharmaceuticals NV
LSE:0RGI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
Wall St Price Targets
0RGI Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for 0RGI is 133.0979 CHF with a low forecast of 102.2357 CHF and a high forecast of 168.3717 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RGI's stock price target?
Price Target
133.0979
CHF
According to Wall Street analysts, the average 1-year price target for 0RGI is 133.0979 CHF with a low forecast of 102.2357 CHF and a high forecast of 168.3717 CHF.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 37%.
